Medroxyprogesterone acetate and megestrol acetate reduce cisplatin-induced serotonin release from human peripheral blood mononuclear cells of cancer patients

Oncology Reports

Volumn 5, Issue 1, 1998, Pages 121-124

  Mantovani, Giovanni ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Anorexia cachexia; Cytokines; Medroxyprogesterone acetate; Megestrol acetate; Peripheral blood mononuclear cells; Serotonin

Indexed keywords

CISPLATIN; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; SEROTONIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON CANCER; DOSE RESPONSE; DRUG EFFECT; FEMALE; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HORMONAL REGULATION; HUMAN; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; MALE; MONONUCLEAR CELL; NAUSEA; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; SEROTONIN RELEASE; VOMITING;

AGED; CELLS, CULTURED; CISPLATIN; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MEDROXYPROGESTERONE 17-ACETATE; MEGESTROL ACETATE; MIDDLE AGED; NEOPLASMS; SEROTONIN;

EID: 0031975547     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.1.121     Document Type: Article

References (2)

1. Andrews PLR, Rapeport WG and Sanger GJ: Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol Sci 9: 334-341, 1988.
2. Seynaeve C, De Mulder PHM and Verweij J: Pathophysiology of cytotoxic drug-induced emesis: far from crystal-clear. Pharm Weekbl Sci 13: 1-6, 1991.